Paul Tudor Jones’s Boston Scientific BSX Stock Holding History

Paul Tudor Jones’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.48M	Sell	198,800 -15,600	-7%	-$847K	0.01%	924
2026 Q1	$13.5M	Buy	214,400 +165,800	+341%	+$13.3M	0.03%	595
2025 Q4	$4.63M	Sell	48,600 -9,100	-16%	-$892K	0.01%	1200
2025 Q3	$5.63M	Sell	57,700 -23,700	-29%	-$2.45M	0.01%	1119
2025 Q2	$8.74M	Buy	81,400 +55,700	+217%	+$5.64M	0.02%	739
2025 Q1	$2.59M	Buy	25,700 +21,100	+459%	+$2.12M	0.01%	1164
2024 Q4	$411K	Sell	4,600 -2,300	-33%	-$202K	﹤0.01%	2372
2024 Q3	$578K	Buy	+6,900	New	+$544K	﹤0.01%	1942
2024 Q2	–	Sell	-7,500	Closed	-$514K	–	2341
2024 Q1	$514K	Buy	+7,500	New	+$482K	﹤0.01%	1638
2023 Q4	–	Sell	-6,300	Closed	-$333K	–	2395
2023 Q3	$333K	Buy	+6,300	New	+$330K	﹤0.01%	1880
2022 Q3	–	Sell	-7,700	Closed	-$286K	–	2321
2022 Q2	$286K	Buy	+7,700	New	+$313K	0.01%	1594
2022 Q1	–	Sell	-5,700	Closed	-$239K	–	2043
2021 Q4	$239K	Buy	+5,700	New	+$240K	﹤0.01%	2021

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paul Tudor Jones's BSX Position: Q2 2026 in Review

Paul Tudor Jones increased its Boston Scientific (BSX) stake by 134% in Q2 2026, buying an estimated $45.9M and bringing the position to 1,477,637 shares worth $63.1M. The position accounts for 0.09% of the portfolio, ranked #160.

Paul Tudor Jones first reported a position in BSX in Q3 2013 and has held it in 34 quarters since. The position peaked at $69.9M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Paul Tudor Jones held 1,477,637 shares of Boston Scientific worth $63.1M as of Q2 2026.
Paul Tudor Jones bought 845,085 Boston Scientific shares in Q2 2026, an estimated $45.9M.
Boston Scientific made up 0.09% of Paul Tudor Jones's portfolio in Q2 2026, its #160 holding.
Paul Tudor Jones first reported a position in Boston Scientific in Q3 2013 and has held it in 34 quarters since.
Paul Tudor Jones's Boston Scientific position peaked at $69.9M in Q2 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.